Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Verma S, et al. Among authors: pocock sj. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. Lancet Diabetes Endocrinol. 2022. PMID: 34861154
Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction.
Rossignol P, Duarte K, Girerd N, Karoui M, McMurray JJV, Swedberg K, van Veldhuisen DJ, Pocock S, Dickstein K, Zannad F, Pitt B. Rossignol P, et al. Among authors: pocock s. Eur J Heart Fail. 2020 Aug;22(8):1402-1411. doi: 10.1002/ejhf.1724. Epub 2020 Jan 9. Eur J Heart Fail. 2020. PMID: 31919958 Free article.
Use of the Win Ratio in Cardiovascular Trials.
Ferreira JP, Jhund PS, Duarte K, Claggett BL, Solomon SD, Pocock S, Petrie MC, Zannad F, McMurray JJV. Ferreira JP, et al. Among authors: pocock s. JACC Heart Fail. 2020 Jun;8(6):441-450. doi: 10.1016/j.jchf.2020.02.010. JACC Heart Fail. 2020. PMID: 32466836 Free article.
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease.
Kaku K, Wanner C, Anker SD, Pocock S, Yasui A, Mattheus M, Lund SS. Kaku K, et al. Among authors: pocock s. Diabetes Obes Metab. 2022 Apr;24(4):662-674. doi: 10.1111/dom.14626. Epub 2022 Feb 9. Diabetes Obes Metab. 2022. PMID: 34908223 Free PMC article. Clinical Trial.
Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction.
Bedrouni W, Sharma A, Pitt B, Lam CSP, Ni J, Ferreira JP, McMurray J, Giannetti N, Girerd N, Rossignol P, Solomon SD, Claggett B, Pocock S, Huynh T, Zannad F. Bedrouni W, et al. Among authors: pocock s. Circ Heart Fail. 2022 Oct;15(10):e009295. doi: 10.1161/CIRCHEARTFAILURE.121.009295. Epub 2022 Aug 4. Circ Heart Fail. 2022. PMID: 35924555 No abstract available.
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced.
Filippatos G, Anker SD, Butler J, Farmakis D, Ferreira JP, Gollop ND, Brueckmann M, Iwata T, Pocock S, Zannad F, Packer M; EMPEROR-Reduced Trial Committees and Investigators. Filippatos G, et al. Among authors: pocock s. Eur J Heart Fail. 2022 Dec;24(12):2297-2304. doi: 10.1002/ejhf.2707. Epub 2022 Oct 24. Eur J Heart Fail. 2022. PMID: 36194680 Free PMC article.
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial.
McGuire DK, Zinman B, Inzucchi SE, Wanner C, Fitchett D, Anker SD, Pocock S, Kaspers S, George JT, von Eynatten M, Johansen OE, Jamal W, Mattheus M, Elsasser U, Hantel S, Lund SS. McGuire DK, et al. Among authors: pocock s. Lancet Diabetes Endocrinol. 2020 Dec;8(12):949-959. doi: 10.1016/S2213-8587(20)30344-2. Lancet Diabetes Endocrinol. 2020. PMID: 33217335 Clinical Trial.
816 results